Liminal BioSciences Inc. (LMNL)

NASDAQ: LMNL · IEX Real-Time Price · USD

0.490

-0.010 (-2.00%)

At close: Aug 10, 2022 3:53 PM

0.471

-0.019 (-3.838%)

After-hours: Aug 10, 2022 7:52 PM EDT

Stock Price Forecast

According to 7 stock analysts, the average 12-month stock price forecast for LMNL stock is $1.08, which predicts an increase of 120.45%. The lowest target is $0.12 and the highest is $2.1. On average, analysts rate LMNL stock as a sell.

Analyst Consensus: Sell

Target	Low	Average	Median	High
Price	$0.12	$1.08	$1.08	$2.1
Change	-75.51%	+120.45%	+120.45%	+328.66%

Analyst Ratings

The average analyst rating for LMNL stock from 7 stock analysts is "Sell". This means that analysts believe this stock is likely to lead to lower returns than market as a whole.

Recommendation Trends

Rating	Feb '22	Mar '22	Apr '22	May '22	Jun '22	Jul '22
Strong Buy	0	0	0	0	0	0
Buy	0	0	0	0	0	0
Hold	4	4	4	4	4	4
Sell	1	1	1	1	1	1
Strong Sell	2	2	2	2	2	2
Total	7	7	7	7	7	7

Financial Forecast

Revenue This Year

n/a

from 643.00K

Revenue Next Year

n/a

EPS This Year

-0.34

from 0.43

EPS Next Year

-0.23

from -0.34

Year	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026
Revenue	22.31M	24.63M	745.00K	724.00K	643.00K	-	-	-	-	-
Revenue Growth	36.12%	10.40%	-96.98%	-2.82%	-11.19%	-	-	-	-	-
EPS	-137.85	-235.95	-12.81	-4.83	0.43	-0.34	-0.23	-0.15	-0.20	-0.26
EPS Growth	-	-	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	4	3	3	1	1

Revenue Forecast

Revenue	2022	2023	2024	2025	2026
High	n/a	n/a	n/a	n/a	n/a
Avg	n/a	n/a	n/a	n/a	n/a
Low	n/a	n/a	n/a	n/a	n/a

Revenue Growth

Revenue Growth	2022	2023	2024	2025	2026
High	-	-	-	-	-
Avg	-	-	-	-	-
Low	-	-	-	-	-

EPS Forecast

EPS	2022	2023	2024	2025	2026
High	-0.35	-0.24	-0.16	-0.21	-0.27
Avg	-0.34	-0.23	-0.15	-0.20	-0.26
Low	-0.32	-0.23	-0.15	-0.19	-0.26

EPS Growth

EPS Growth	2022	2023	2024	2025	2026
High	-	-	-	-	-
Avg	-	-	-	-	-
Low	-	-	-	-	-